Absolutely. In my mind the simplest way to look at it is shortly we may well have clinical proof that rce 327 or whatever variant they use will kill gram positive and gram negative bacteria in wounds on human subjects. Ghat is massive for a new strain of anti biotic with totally different action to existing. Hopefjlly they get good results and can maybe even find some "superbugs" to trial it on. I would assume now they have ethical approval the hospital will be keen to try it on whatever appears in the burns ward, and the better it works the more they will want to keep using it.
RCE Price at posting:
$1.11 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)